Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Debt-to-Equity : 9.12 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Debt-to-Equity?

Zhong Yuan Bio-Technology Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $1.67 Mil. Zhong Yuan Bio-Technology Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.64 Mil. Zhong Yuan Bio-Technology Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $0.25 Mil. Zhong Yuan Bio-Technology Holdings's debt to equity for the quarter that ended in Sep. 2023 was 9.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Zhong Yuan Bio-Technology Holdings's Debt-to-Equity or its related term are showing as below:

ZHYBF' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.86 Med: 1.17 Max: 9.12
Current: 9.12

During the past 8 years, the highest Debt-to-Equity Ratio of Zhong Yuan Bio-Technology Holdings was 9.12. The lowest was -5.86. And the median was 1.17.

ZHYBF's Debt-to-Equity is ranked worse than
98.66% of 1637 companies
in the Consumer Packaged Goods industry
Industry Median: 0.41 vs ZHYBF: 9.12

Zhong Yuan Bio-Technology Holdings Debt-to-Equity Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Debt-to-Equity Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.14

0.49

1.13

1.77

-5.86

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial								1.21	1.77	4.26	-5.86	9.12

Competitive Comparison of Zhong Yuan Bio-Technology Holdings's Debt-to-Equity

For the Packaged Foods subindustry, Zhong Yuan Bio-Technology Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhong Yuan Bio-Technology Holdings's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Zhong Yuan Bio-Technology Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Zhong Yuan Bio-Technology Holdings's Debt-to-Equity falls into.

Zhong Yuan Bio-Technology Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Zhong Yuan Bio-Technology Holdings's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.438	+	0.596)	/	-0.347
	=	-5.86

Zhong Yuan Bio-Technology Holdings's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.668	+	0.64)	/	0.253
	=	9.12

Zhong Yuan Bio-Technology Holdings (OTCPK:ZHYBF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Zhong Yuan Bio-Technology Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines